4th Quarter - Report

ARTHRITIS FOUNDATION for ARTHRITIS FOUNDATION

Firm
Client
Income
—
Expenses
$65,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

HR 1600 Patients' Access to Treatments Act HR 6 21st Century Cures/Innovation for Healthier Americans HR 1859 Physician Workforce/Pediatric Subspecialty Loan Repayment Biosimilars guidance, oversight FDA

LobbyistCovered position, as disclosed
ANNA HYDE Director, Health Policy and Federal Affairs
SANDIE J. PREISS Vice President, Advocacy and Access

Contacted: Office of Management & Budget (OMB); Centers For Disease Control & Prevention (CDC); Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 1600 (114th), H.R. 6 (114th), H.R. 1859 (114th)

Medicare/Medicaid MMM

Medicare Part B and D Telemedicine Medicaid CHIP CHIP Re-authorization S.776 Medication Therapy Management Empowerment Act of 2015 HR 2624/S1488 Part D Beneficiary Appeals Fairness Act

LobbyistCovered position, as disclosed
ANNA HYDE Director, Health Policy and Federal Affairs
SANDIE J. PREISS Vice President, Advocacy and Access

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE; Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Office of Management & Budget (OMB); Natl Institutes of Health (NIH)

Bills named: S. 776 (114th), H.R. 2624 (114th)

Budget/Appropriations BUD

FY 17 appropriations for HHS, CDC, NIH, DoD, FDA FY 17 budget and appropriations Budget Control Act Bipartisan Budget Act PADUFA re-auhorization ACA Implementation H.R 2029- FY 16 Omnibus HR 1859 Physicians Workforce/ Pediatric Subspecialty Loan Repayment Biosimilars guidance, oversight Medicare Parts B, C, & D - Part D Beneficiary/ Appeals Fairness Act Medicar Part D Bill HR 2624 Medicare Managed Care CMS - S. 776 Medication Therapy Management Empowerment Act

LobbyistCovered position, as disclosed
ANNA HYDE Director, Health Policy and Federal Affairs
SANDIE J. PREISS Vice President, Advocacy and Access

Contacted: Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); Defense, Dept of (DOD); SENATE; Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH)

Bills named: S. 776 (114th), H.R. 2029 (114th), H.R. 2624 (114th), H.R. 1859 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.